Building a Global AI Venture for Medical Imaging Analysis from India: Prashant Warier, CEO of Qure.ai (Part 6)

Sramana Mitra: When did you enter the US? Before of after the Sequoia funding?

Prashant Warier: Just before the Sequoia funding, we hired our Chief Commercial Officer, but we didn’t have FDA clearance. FDA clearance came in 2021. Our real traction was in 2022. Even now, we are very small in the US. We have some commercial traction, but we’ve a long way to go. The other thing is that we are able to identify patients early.

Featured Videos

618th 1Mby1M Roundtable Recording

In case you missed it, you can listen to the recording of this roundtable here:

Roundtable Recap: September 14 – Proven Business Models Spreading Far and Wide

During this week’s roundtable, we worked with two interesting businesses.

No Sweat Clothes

First up, we had Martin Aker from Oslo, Norway, pitching No Sweat Clothes, a niche e-commerce business already in revenue.

MIAH

Then Emmanuel Akandwanaho from Kamala, Uganda, pitched MIAH, a SaaS-enabled marketplace venture.

You can listen to the recording of this roundtable here:

>>>

Video FAQs

Building a Global AI Venture for Medical Imaging Analysis from India: Prashant Warier, CEO of Qure.ai (Part 5)

Sramana Mitra: When you validated the TB use case in 2018, did you put that as your only use case? Were you doing other radiology use cases as well?

Prashant Warier: We had a lot of other use cases. We are also working on a head CT product. Chest X-rays has a high volume. The other one requires speed. AI can manage volume and speed. Head CTs are taken when you’re looking at critical cases. When you want to do something quickly, you do a CT. You need a fast interpretation there. For a stroke patient, for every minute that goes by, brain cells are dying. You want to intervene quickly.

618th 1Mby1M Roundtable for Entrepreneurs Starting NOW: Live Tweeting by @1Mby1M

Today’s 618th FREE online 1Mby1M Roundtable for Entrepreneurs is starting NOW, on Thursday, September 14, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

618th Roundtable for Entrepreneurs Starting in 30 Minutes: Live Tweeting by @1Mby1M

Today’s 618th FREE online 1Mby1M Roundtable for Entrepreneurs is starting in 30 minutes, on Thursday, September 14, at 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST/8:30 p.m. India IST. CLICK HERE to join. PASSWORD: startup  All are welcome!

Best of Bootstrapping: Bootstrapped an AI Startup Using Services

If you haven’t already, please study our Bootstrapping Course and Investor Introductions page. 

Co-founder Nitesh Chawla bootstrapped Aunalytics while keeping his academic job at Notre Dame. Here is our conversation from 2021.

Sramana Mitra: Let’s start at the very beginning of your story. Where are you from? Where you born, raised, and in what kind of background?

Nitesh Chawla: I’m from New Delhi although I was born in Calcutta. I did my schooling from Delhi Public School. Then I did my engineering from Pune. Then I came to the United States in 1993 right after finishing my undergrad. I went to grad school in South Florida. I got my PhD in Computer Science with a focus on Machine Learning and Data Science.

>>>

Building a Global AI Venture for Medical Imaging Analysis from India: Prashant Warier, CEO of Qure.ai (Part 4)

Sramana Mitra: How did you find this customer?

Prashant Warier: TB is not one of those things that you can identify on an X-ray. If there is TB, it is likely that the X-ray will show some abnormality, but not every abnormality is likely to be TB. It could be other kinds of disease. Even COVID might look somewhat similar. It’s not precise. The patient comes in and takes an X-ray. If the X-ray is positive, you can do a microbiological test. That is a confirmation.